(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid,
MK 8245,
MK-8245,
MK8245,
MK-8245,
1030612-90-8,
MK8245,
MK 8245,
UNII-537E7QE8LX,
537E7QE8LX,
CHEMBL1938870,
5-[3-[4-(2-Bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-2H-tetrazole-2-acetic acid,
2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid,
2H-Tetrazole-2-acetic acid, 5-[3-[4-(2-bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-;2H-Tetrazole-2-acetic acid, 5-[3-[4-(2-bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-,
UJEAABFSXKCSGI-UHFFFAOYSA-N,
C17H16BrFN6O4,
MLS006011144,
SCHEMBL472978,
DTXSID80145625,
HMS3654I12,
BCP02516,
EX-A2267,
KS-00000XJ9,
ABP000840,
BDBM50362592,
MFCD20039622,
s1158,
ZINC43195878,
AKOS026750582,
CS-0410,
DB13024,
SB19577,
2H-Tetrazole-2-acetic acid, 5-(3-(4-(2-bromo-5-fluorophenoxy)-1-piperidinyl)-5-isoxazolyl)-,
NCGC00346680-01,
NCGC00346680-05,
AC-28436,
AS-19554,
BC638824,
HY-13070,
SC-94521,
SMR004702921,
SW220251-1,
Y0300,
A11403,
W-5823,
(5-{3-[4-(2-Bromo-5-fluorophenoxy)piperidin-1-yl]isoxazol-5-yl}-2H-tetrazol-2-yl)acetic acid,
D0S0RS,
MK-8245 Trifluoroacetate,
cc-136,
A3625,
A4345,
C561635,
(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid,
1030612-87-3,
1030613-40-1,
1415559-41-9,
5-[3-[4-(2-Bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-2H-tetrazole-2-acetic acid(MK-8245),